Scroll Top

Scientific Info

Click on the button below to download the Preliminary Program at a Glance of the Congress.

Drylabs

The EGS is pleased to present a Dry Lab Selection for the 16th EGS Congress in Dublin, 1-4 June 2024.

Launched by the EGS for the first time and delivered by internationally renowned glaucoma surgeons, the dry labs will cover all aspects of glaucoma surgery, from ‘conventional’ filtration surgery to newer techniques and devices. Participants will have the opportunity to develop not only the technical skill set, but also an in-depth understanding of the role of these procedures in glaucoma care.

There is a limited number of attendees for each lab, so please register as soon as possible to reserve your seat.

Please note that the labs can only be booked in combination with a congress registration. 

Check the schedule here and click on the preferred date to choose the dry labs slots: 

1) Bleb forming devices 

2) Tubes

3) MIGS – Dilating 

1) MIGS – Stenting 

2) Trabeculectomy 

1) MIGS – Stenting 

2) Bleb forming devices 

3) Trabeculectomy 

1) MIGS – Disruptive/Suprachoroidal 

2) Tubes 


Abstracts Information

The Scientific Committee invites you to participate actively in this congress which will be an extraordinary occasion for the exchange of thoughts and experiences. We look forward to receiving abstracts for consideration and inclusion in the programme as oral or poster presentations.

NEW Deadline for abstracts submission:

12 February 2024

Mark these dates

12 February 2024 Deadline for abstracts submission

19 March 2024 Notification of acceptance or rejection for abstracts

Registration for the Congress is mandatory for presenting authors. 

The presenting author of an abstract must be registered by 4 April 2024. 

Abstract preparation

Experiments and data must be completed at the time of the abstract submission.

The following subdivision of abstract is MANDATORYPurpose, Methods, Results, Conclusions. Abstracts lacking a description of study methodology and a quantitative description of data will not be accepted. Abstracts without a topic category indicated will not be reviewed.

The Scientific Programme Committee aims for ‘to the point’ informative abstracts.

Extensive presentations overloaded with details should be avoided.

Multiple submissions of the same topic on different abstracts will be rejected.

The Abstract must be written in English.

Rules for abstracts submision
  • Abstracts should be unpublished work at the time of presentation.
  • Abstracts submission is possible on-line through the website only. Abstracts submitted by email, fax or post will not be accepted.
  • The on-line abstract submission is available from 20 October 2023 through 15 January 2024, 11:00 p.m. local time (CET) on the congress website.
  • Abstract length is limited to 350 words (tables and graphics included).
  • The submitting author creates a personal account with email address and password and can submit, edit or delete abstracts until the submission deadline. At no time the Organizing Secretariat Staff can make any changes to abstracts.
  • An individual may be first author (i.e. presenting author) of only one abstract.

The presenting author’s name must be the first name on the author’s list. It is permitted to be a co-author of an unlimited number of abstracts. Presenting authors (first authors) are expected to attend the congress and present their poster. Authors who are unable to attend and give the presentation as scheduled, must notify the Organizing Secretariat OIC and withdraw their abstract at abstractEGS@oic.it

  • All accepted abstracts will be assigned to poster and some of them will be selected for rapid fire presentation at the discretion of the EGS Scientific Committee.

Once programmed, abstract presentation times and locations cannot be changed.

  • The Scientific Committee reserves the right to reject abstracts.
  • All abstracts will be reviewed by the Scientific Committee. The reviewing process is strictly confidential and all reviewers have agreed to the following: “I understand the confidential nature of the abstracts, and I will not discuss their contents with any individual, nor will I make copies of abstracts for my own or others’ use. In addition, I will not review any abstracts where conflict of interest may be perceived, i.e., work on which I have authored or co-authored or work completed in laboratories where I work.”
Note

When selecting an abstract category, please choose carefully. The abstract Category you select will determine which Scientific Section your abstract will be destined.

Topics (abstract categories)

Diagnosis

01 Diagnosis – Glaucoma all types

02 Diagnosis – Primary open-angle glaucoma

03 Diagnosis – Angle closure glaucoma

04 Diagnosis – Congenital / Pediatric glaucoma

05 Diagnosis – Secondary glaucomas

Genetics

06 Genetics – Glaucoma all types

07 Genetics – Primary open-angle glaucoma

08 Genetics – Angle closure glaucoma

Follow up/Progression

09 Follow up – Glaucoma all types

10 Follow up – Primary open-angle glaucoma

11 Follow up – Angle closure glaucoma

12 Follow up – Congenital/Pediatric glaucoma

13 Follow up – Secondary glaucomas

Treatment – Medical

14 Treatment – Glaucoma all types

15 Treatment – Primary open-angle glaucoma

16 Treatment – Angle closure glaucoma

17 Treatment – Congenital / Pediatric glaucoma

18 Treatment – Secondary glaucomas

19 Treatment – Neuroprotection

Treatment – Surgery/Laser

20 Treatment – Glaucoma all types

21 Treatment – Primary open-angle glaucoma

22 Treatment – Angle closure glaucoma

23 Treatment – Congenital / Pediatric glaucoma

24 Treatment – Secondary glaucomas

Epidemiology, health economics, visual disability,

25 Epidemiology, health economics, visual disability, QoL – Glaucoma all types

26 Epidemiology, health economics, visual disability, QoL – Primary open-angle glaucoma

27 Epidemiology, health economics, visual disability, QoL – Angle closure glaucoma

28 Epidemiology, health economics, visual disability, QoL – Congenital / Pediatric glaucoma

29 Epidemiology, health economics, visual disability, QoL – Secondary glaucomas

Pathogenesis

30 Pathogenesis – Glaucoma all types

31 Pathogenesis – Primary open-angle glaucoma

32 Pathogenesis – Angle closure glaucoma

33 Pathogenesis – Congenital /Pediatric glaucoma

34 Pathogenesis – Secondary glaucomas

35 Machine learning/AI

Language

The official language of the congress is English.

DISCLAIMER

Please note that the website contains third-party scientific contents uploaded for educational purposes. Images may have been included in these contents.

It should be noted that the authorship of such scientific contents and images does not belong to the Organizing Secretariat (OIC S.r.l.) or to the Scientific Society. These subjects are not responsible for what is expressed and/or represented therein, declining any liability to the actual authors/owners, whose personal and contact data can be obtained by contacting the Organizing Secretariat at the address indicated below, for the exclusive purpose of protecting intellectual property rights and/or copyright.


For more information please contact the Help Desk:

OIC S.r.l., Viale della Giovine Italia, 17 | 50122, Florence – Italy

Tel.: +39 055 50351 | Fax: +39 055 500 1912

AbstractEGS@oic.it